#MentalHealth #Entheogens #DepressionTreatment #Neuroplasticity #antidepressants #pharmaceuticals To view or add a comment, sign in 💊 Should patients really stop antidepressants before entheogen therapy?

  • Environmental factors like stress or relationship issues can override drug effects.
  • The drugs facilitate the physical response but do not create desire.
  • A low libido (sex drive) may need to be addressed separately.
  • Testosterone replacement therapy might be considered if levels are low.
  • The combination does not protect against sexually transmitted infections (STIs).
  • Safe sex practices remain important regardless of medical treatment.
  • There is no interaction between these drugs and condoms or lubricants.
  • The treatment is for heterosexual and homosexual men alike.
  • The principles of diagnosis and treatment apply regardless of sexual orientation.
  • Cultural and religious beliefs may influence a patient's decision to pursue treatment.
  • A doctor must provide culturally sensitive care and respect patient choices.

To view or add a comment, sign in Collaborence is the signature conference of the Psilocybin Assisted Therapy Association, a national nonprofit dedicated to advancing education, collaboration, and innovation in the world of psilocybin-assisted therapy. Designed for both professionals and the public, this event brings together leading voices in mental health, psychedelic research, and community advocacy to share evidence-based insights and diverse perspectives.

Tham khảo

• Overall lifestyle (diet, exercise, weight, and not smoking) also strongly affects prostate health. • Men should still get regular prostate screenings as recommended by their doctor. ✅ Summary: Research suggests that around 21 ejaculations per month (roughly 4–5 times per week) is associated with the lowest risk of prostate cancer in men, compared with lower frequencies. To view or add a comment, sign in 𝐆𝐋𝐏-1 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐚𝐧𝐝 𝐓𝐡𝐞𝐢𝐫 𝐄𝐦𝐞𝐫𝐠𝐢𝐧𝐠 𝐑𝐨𝐥𝐞 𝐢𝐧 𝐀𝐥𝐜𝐨𝐡𝐨𝐥 𝐚𝐧𝐝 𝐒𝐮𝐛𝐬𝐭𝐚𝐧𝐜𝐞 𝐔𝐬𝐞 𝐃𝐢𝐬𝐨𝐫𝐝𝐞𝐫𝐬: 𝐀𝐧 𝐄𝐧𝐝𝐨𝐜𝐫𝐢𝐧𝐨𝐥𝐨𝐠𝐲 𝐏𝐫𝐢𝐦𝐞𝐫 Very interesting review just published in The Journal of the Endocrine Society by Nirupam Srinivasan and colleagues. ✍Alcohol and other substance use disorders (ASUDs) are complex, multifaceted, but treatable medical conditions with widespread medical, psychological, and societal consequences.

ATC (Anatomical Therapeutic Chemical Classification)

✍However, treatment options remain limited, therefore the discovery and development of new treatments for ASUDs is critical. ✍Glucagon-like peptide-1 receptor agonists (GLP-1RAs), currently approved for the treatment of type 2 diabetes mellitus, obesity, and obstructive sleep apnea, have recently emerged as potential new pharmacotherapies for ASUDs. ✍Following an overview of the epidemiology, biology, consequences, and treatments of ASUDs, this review provides a summary of the emerging role of GLP-1RAs in the treatment of ASUDs by elucidating their interactions with various neurobiological pathways involved in addiction. ✍It also highlights existing gaps in research, future directions, and broader implications related to the potential use of GLP-1RAs for addiction treatment. 🤓 Very interesting topic and well written paper 🤓Most of the times we talk about alcohol addiction and GLP-1RAs, however the topic si much broader. Through panels, discussions, and networking, attendees are empowered to make informed decisions about the role of psilocybin in their personal and professional lives, while fostering connections that build stronger, more collaborative communities.

Product Dosage Quantity + Bonus Price
Cialis Generic60mg360 + 10 Pills570.52€ 543.35€
Priligy Generic Dapoxetine60mg20 + 4 Pills77.31€ 73.63€
Priligy Generic Dapoxetine60mg60 + 8 Pills183.06€ 174.34€
Cialis Original20mg8 Pills61.70€ 58.76€
Cialis Generic10mg20 Pills48.23€ 45.93€
Priligy Generic Dapoxetine60mg30 + 6 Pills106.65€ 101.57€
Priligy Generic Dapoxetine60mg10 Pills47.63€ 45.36€
Priligy Generic Dapoxetine60mg120 + 10 Pills341.26€ 325.01€
Cialis Professional20mg20 Pills78.33€ 74.60€
Priligy Generic Dapoxetine60mg90 + 10 Pills265.64€ 252.99€
Priligy Generic Dapoxetine60mg180 + 10 Pills494.76€ 471.20€
Kamagra Gold100 mg60 + 4 Pills201.34€ 191.75€
Apcalis SX Oral Jelly20mg120 + 13 Sachets280.38€ 267.03€
Levitra Soft Tabs20mg120 + 8 Pills288.52€ 274.78€
Viagra Professional100mg180 + 4 Pills337.30€ 321.24€

Happening October 4-5, 2025, day one of The Collaborence offers online training and connection, and day two will feature two in-person expos: one in Portland, Oregon and one in Boulder, Colorado. Be sure to check out Psychedelic Pharmacists Association members at: Day 1 October 4th Online 12:55pm – 1:40pm Psychedelics as Medicine: The Pharmacist’s Perspective Colby Burns, PharmD, MBA; April Huynh; Lauren Blue, PharmD, MS.

  • Use dapoxetin with caution in patients with depression or anxiety.
  • Sildenafil should be used with caution in those with heart conditions.
  • Proper dosing and timing optimize safety and effectiveness.

; Andy Krut; and Anne M Berg will explore the pharmacist’s role in evaluating and supporting psilocybin use for patients with complex comorbidities. Participants will walk away understanding: 💊 Key pharmacologic considerations, including psilocybin’s absorption, distribution, metabolism, excretion, and toxicity (ADMET), along with risks of combining psilocybin with other psychoactive or prescription substances.

Tác dụng phụ

The Journal of Biological Chemistry, 286(9), 6825–6838.) To view or add a comment, sign in Recent research demonstrates that gender-affirming hormone therapy can significantly alter blood protein profiles in transgender women, aligning them more closely with those of cisgender women. These changes may influence susceptibility to certain health conditions, including autoimmune diseases and heart disease. The findings highlight the importance of nuanced, long-term health monitoring and suggest that personalized treatment approaches could enhance care for individuals undergoing hormone therapy. This research underscores the adaptability of human biology and the need for healthcare providers to consider both shared and unique health risks in transgender women. To view or add a comment, sign in Recent research demonstrates that gender-affirming hormone therapy can significantly alter blood protein profiles in transgender women, aligning them more closely with those of cisgender women.

Molecular Weight

To view or add a comment, sign in Here’s what research shows: 🔹 Key Study: A large 2016 study published in European Urology (by researchers from Harvard University) followed more than 30,000 men for almost two decades. They found that: • Men who ejaculated 21 or more times per month had about a 20% lower risk of developing prostate cancer than those who ejaculated 4–7 times per month. 🔹 What counts: Ejaculation frequency includes sex with a partner, masturbation, or nocturnal emissions. 🔹 Why it may help: More frequent ejaculation may help clear potentially harmful substances from the prostate and reduce inflammation, though the exact biological reason is still being studied. 🔹 Important context: • It’s not a prescription — just a correlation, not proof of cause and effect. Special emphasis will be placed on drug–drug interaction screening, including the implications of tapering or discontinuing SSRIs.

  • The legal status of dapoxetine varies significantly more than sildenafil.
  • In some countries, dapoxetine is not available at all, making combination impossible.
  • Telemedicine consultations have made access to specialists for these issues easier.
  • However, a physical examination is often still required for a first-time prescription.
  • Blood tests may be ordered to rule out hormonal causes like low testosterone.
  • The role of the partner in treatment success and support should not be underestimated.
  • Couples therapy can address relational issues that contribute to sexual dysfunction.
  • The drugs treat the symptoms, not necessarily the root cause of the problems.
  • A healthy lifestyle with exercise and a good diet can improve overall sexual health.
  • Smoking cessation is highly recommended, as it is a major cause of vascular ED.
  • Managing stress through techniques like mindfulness can also be beneficial.

🍄 What to expect during a psilocybin session, with attention to physiologic and psychological warning signs that warrant intervention.

Precautions to Follow

🤓 Preclinical studies have consistently demonstrated the potential of GLP-1RAs in reducing the consumption and rewarding properties of alcohol, opioids, nicotine, and psychostimulants. 🤓Clinical studies remain limited for most substances but early results show reductions in cravings, substance use, and other related outcomes. Definitely worth reading!👍👏😀 To view or add a comment, sign in 𝐆𝐋𝐏-1 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐚𝐧𝐝 𝐓𝐡𝐞𝐢𝐫 𝐄𝐦𝐞𝐫𝐠𝐢𝐧𝐠 𝐑𝐨𝐥𝐞 𝐢𝐧 𝐀𝐥𝐜𝐨𝐡𝐨𝐥 𝐚𝐧𝐝 𝐒𝐮𝐛𝐬𝐭𝐚𝐧𝐜𝐞 𝐔𝐬𝐞 𝐃𝐢𝐬𝐨𝐫𝐝𝐞𝐫𝐬: 𝐀𝐧 𝐄𝐧𝐝𝐨𝐜𝐫𝐢𝐧𝐨𝐥𝐨𝐠𝐲 𝐏𝐫𝐢𝐦𝐞𝐫 Very interesting review just published in The Journal of the Endocrine Society by Nirupam Srinivasan and colleagues. To view or add a comment, sign in ICD-10-CM Diagnosis Code Updates Total changes: 252 new codes, 36 deletions, 13 revisions Notable additions by chapter: Chapter 2 (Neoplasms): New codes for Hodgkin lymphoma in remission (e.g., C81.0A–C81.9A) Chapter 4 (Endocrine): Presymptomatic Type 1 diabetes (E10.A-), new obesity classifications (E66.811–E66.813), and MC4R pathway-related obesity (E88.82) Chapter 5 (Mental Disorders): Expanded eating disorder codes including anorexia nervosa subtypes, binge eating disorder, pica, and rumination disorder in adults Chapter 6 (Nervous System): New epilepsy codes (e.g., G40.84 for KCNQ2-related epilepsy), serotonin syndrome (G90.81), and developmental encephalopathy (G93.45) Chapter 9 (Circulatory System): Expanded pulmonary embolism codes (I26.03–I26.96) Chapter 10 (Respiratory System): New codes for nasal valve collapse under acute bronchiolitis (J21) 🛠️ ICD-10-PCS Procedure Code Updates These updates also take effect October 1, 2025, and apply to inpatient procedures through September 30, 2026. To view or add a comment, sign in 💊 Should patients really stop antidepressants before entheogen therapy?

CAS registry number (Chemical Abstracts Service)

A new 2025 review challenges one of the field’s most rigid assumptions. For decades, clinical trials with psilocybin, LSD, and DMT have required participants to discontinue antidepressants (SSRIs, SNRIs, MAOIs, etc.) weeks before an entheogen session. To “avoid serotonin syndrome” and “preserve the full psychedelic experience.” But the latest scoping review by Tap et al. (2025, Journal of Psychopharmacology) suggests this protocol may be both outdated and harmful. After analyzing 19 human studies across psilocybin, LSD, DMT, and ayahuasca, the authors found that: 🧠 Safety: There’s no robust evidence that taking antidepressants with classic entheogens increases the dapoxetine over counter risk of serotonin toxicity — particularly with psilocybin. 🥼 Pharmacist’s unique role across the continuum of care: ensuring safe screening, optimizing medication management, mitigating risks, and serving as a collaborative resource for patients and care teams engaging with psilocybin therapy.

  • The economic burden of untreated sexual dysfunction can be significant.
  • It can lead to relationship breakdown, anxiety, and depression.
  • Effective treatment can improve overall mental health and well-being.
  • The cost of medication must be weighed against these potential benefits.
  • Patient assistance programs may be available for those who cannot afford treatment.
  • The global market for ED and PE medications is vast and highly profitable.
  • This commercial interest drives both innovation and questionable marketing practices.
  • Patients should rely on information from unbiased medical sources.
  • Websites of national health services or medical associations are reliable.
  • Forums and social media can spread misinformation and should be used cautiously.
  • The decision to treat should be based on medical need, not commercial pressure.

Day 2 October 5th Boulder, CO 🔹 10:30am – 4:30pm Kristin Speer, PharmD, BCPS and Erika Beerbower will be in the exhibition hall 🔸 1:30pm - 2:15pm Beyond Psychotropics: Relevant Psilocybin Interactions You Don't Want to Miss Dr.

Interaction Type Dapoxetin Sildenafil
Other SSRIs or SNRIs Increased risk of serotonin syndrome No significant interaction
Nitrates Contraindicated Contraindicated
Alpha-blockers Use cautiously, risk of hypotension Use cautiously, risk of hypotension
CYP3A4 Inhibitors Increased dapoxetin levels Increased sildenafil levels
CYP3A4 Inducers Reduced efficacy Reduced sildenafil levels

Kristin Speer, PharmD, BCPS, Kristin Speer, PharmD, BCPS will be discussing how psilocybin drug interaction info often focuses narrowly on psychotropics such as antidepressants, antipsychotics, and lithium.

Can I increase the dose of dapoxetine?

Most side effects (headache, mild nausea, temporary increases in blood pressure) were comparable to placebo. 💫 Efficacy: Even when antidepressants slightly blunted the intensity of the entheogenic experience, the therapeutic outcomes for depression and anxiety remained significant. In some studies, patients on antidepressants improved as much or more than those who discontinued them. ⚠️ Risks of discontinuation: Forcing patients to stop antidepressants can lead to relapse, withdrawal symptoms, and suicidal ideation — all before entering a psychologically open and vulnerable state. In other words: the “washout” phase may do more harm than the drug combination itself.

Quá liều

🌱 The takeaway: Continuing antidepressants during entheogen-assisted therapy may actually increase accessibility and safety for millions who currently can’t participate in research or treatment. This isn’t just a pharmacological question — it’s an ethical one. If the future of mental health care is truly integrative, it must balance neurobiology with compassion, and clinical safety with real-world inclusion. Rigorous, trauma-informed trials that investigate how antidepressants modulate neuroplastic and subjective mechanisms of entheogenic therapy — without retraumatizing those who rely on them daily. Because healing shouldn’t require withdrawal to begin.